Last reviewed · How we verify
B.microti diagnostic blood tests — Competitive Intelligence Brief
phase 3
Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
B.microti diagnostic blood tests (B.microti diagnostic blood tests) — Imugen. This diagnostic blood test detects Babesia microti parasites or antibodies to identify babesiosis infection in patients.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| B.microti diagnostic blood tests TARGET | B.microti diagnostic blood tests | Imugen | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- B.microti diagnostic blood tests CI watch — RSS
- B.microti diagnostic blood tests CI watch — Atom
- B.microti diagnostic blood tests CI watch — JSON
- B.microti diagnostic blood tests alone — RSS
Cite this brief
Drug Landscape (2026). B.microti diagnostic blood tests — Competitive Intelligence Brief. https://druglandscape.com/ci/b-microti-diagnostic-blood-tests. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab